Details for Patent: 6,001,861

Title:	Use of pramipexole in the treatment of restless legs syndrome
Abstract:	The present invention provides the use of pramipexole in the treatment of restless legs syndrome.
Inventor(s):	Oertel; Wolfgang H. (Ranschenberg, DE), Meier; Dieter (Weisbaden, DE), Gomez-Mancilla; Baltazar (Portage, MI), Montplaisir; Jacques (Montreal, CA)
Assignee:	Pharmacia & Upjohn Company (Kalamzoo, MI)
Filing Date:	Jan 16, 1998
Application Number:	09/008,212
Claims:	1. A method for treating restless legs syndrome in a patient suffering from or susceptible to such condition comprising the administration of an effective amount of the compound 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole, its (-)-enantiomer thereof, and pharmacologically acceptable salts thereof. 2. A method for treating restless legs syndrome in a patient suffering from or susceptible to such condition comprising the administration of an effective amount of Pramipexole, its dihydrochoride, or its dihydrochloride-(H.sub.2 O) thereof. 3. The method of claim 2, wherein the dose of Pramipexole is about 0.01-10.0 mg/day. 4. The method of claim 2, wherein the dose of Pramipexole is between about 0.75-4.5 mg/day.